Ditte Møller Ejegod

Methylation markers <scp><i>FAM19A4</i></scp> and <i><scp>miR124</scp>‐2</i> as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

Jesper Bonde, Arno Floore, Ditte Møller Ejegod et al. · International Journal of Cancer · 2020 · 124 citations · Full text

Medicine, Oncology, Pathology +17

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening

Matejka Rebolj, Sarah Preisler, Ditte Møller Ejegod et al. · PLoS ONE · 2014 · 77 citations · Full text

Medicine, Oncology, Pathology +17

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay

Sarah Preisler, Matejka Rebolj, Anette Untermann et al. · PLoS ONE · 2013 · 57 citations · Full text

Medicine, Oncology, Pathology +17

Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms

Janni Uyen Hoa Lam, Matejka Rebolj, Ditte Møller Ejegod et al. · International Journal of Cancer · 2017 · 55 citations · Full text

Medicine, Preventive Medicine, Public Health Practice +17

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system

Jesper Bonde, Matejka Rebolj, Ditte Møller Ejegod et al. · BMC Infectious Diseases · 2014 · 50 citations · Full text

Medicine, Gynecology, Preventive Medicine +17